ArticlePoultry science2026
Co-immunization with two recombinant Newcastle disease viruses expressing ILTV gB and H9N2 AIV HA confers protective efficacy against three avian pathogens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Newcastle disease virus (NDV) has been well established as a versatile vector platform for heterologous antigen delivery in poultry vaccine development. However, the prospects for combined application of two recombinant NDV (rNDV) vaccines remain poorly understood. In previous studies, we generated two rNDVs based on the thermostable TS09-C strain, expressing glycoprotein B (gB) of infectious laryngotracheitis virus (ILTV) and hemagglutinin (HA) of the H9N2 subtype avian influenza virus (H9N2 AIV). In the present study, we evaluated the potential interference between the two rNDVs and using both in vitro and in vivo models. When two rNDVs co-infected BHK-21 and CEK cells, their viral replication kinetics and expression levels of heterologous antigens (gB and HA) were comparable to those in the respective single-virus infection groups. This finding indicates that the two rNDVs do not exhibit significant interference in vitro. SPF chickens co-immunized with the two rNDVs via intranasal and intraocular routes elicited effective H9N2-, ILTV-, and NDV-specific antibody responses comparable to those in the single-virus immunization group. Compared with control chickens, co-immunized chickens displayed milder clinical signs and reduced viral shedding following challenge with H9N2 AIV, ILTV, and NDV. Based on these findings, spray co-immunization was further tested in commercial chickens and proven to confer effective protection against challenges with NDV, H9N2 AIV, and ILTV. In conclusion, this study confirms the feasibility of co-immunization using the two rNDVs, thereby providing a highly viable strategy for the simultaneous control of multiple avian pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.